If you have an HPV-positive cancer, like mouth or throat cancer
Your Blood TTMV® Score
Can Guide the Way
Why wait for physical symptoms to appear?
Routine NavDx testing assists in earlier detection of recurrent disease
Published studies show that NavDx testing accurately and reliably
predicted when cancer returned.
Among post-treatment patients:
≥98%
of people whose TTMV score remained negative had no cancer recurrence
≥95%
of people with one positive TTMV score had recurrence
Routine monitoring with the NavDx test can help detect cancer recurrence a median of 4 months earlier than imaging biopsies, or symptoms.
Plan Your Next NavDx Surveillance Test
Be assured of your true cancer status with routine NavDx testing
Which type of HPV-driven cancer were you treated for:
Speak with your provider to set up a NavDx testing schedule that's right for you!
Your physician can rely on NavDx testing to track your TTMV® Score and
personalize your care during every phase of treatment
Is a NavDx test required before starting treatment?
No, NavDx testing can be used to detect recurrence without having a baseline TTMV Score. Pretreatment testing is only recommended for newly diagnosed patients.
Can NavDx testing show if my cancer is responding to treatment?
Yes, tracking changes in your TTMV Score help to assess your response to treatment.
Discuss all your TTMV Scores with your physician to stay informed of your true cancer status
NavDx testing can significantly improve your
HPV-positive cancer treatment plan
Routine NavDx testing to track changes in your TTMV Score offers your physician a more complete picture of your cancer status than imaging scans alone. With a simple blood draw, a NavDx test can detect whether the tumor has returned even before symptoms appear, helping your physician create the best care plan for you.
To optimize your care, your physician relies on NavDx to:
- Help rule out recurrence and provide peace of mind during your ongoing post-treatment surveillance
- Assist in accurate detection of cancer recurrence before symptoms appear, because knowing sooner may improve your ability to fight the disease
Routinely test with the NavDx blood test and be assured of your TTMV Score and cancer status
In the management of HPV-positive cancer
Your Blood has never been more important
What is a blood TTMV Score?
TTMV-HPV DNA, or tumor tissue modified viral-HPV DNA, is a tumor biomarker that is specific for HPV-positive cancers. A blood TTMV Score is the unique result for a NavDx test, which quantifies circulating TTMV-HPV DNA fragments in your blood. Tracking changes in your TTMV Score gives your physician important information about your HPV-positive cancer status.
What is a biomarker?
A biomarker is a molecule that can be objectively measured in a laboratory test to give your physician more information about your cancer status.
Frequently asked questions (FAQs)
regarding NavDx testing
Review our FAQs to read more information about the NavDx test and other related topics
Explore FAQsMaterials and support for HPV-positive cancer
patients and their loved ones
From downloadable materials and patient support to advocacy organizations and cancer education,
Naveris® is committed to supporting you throughout your journey.
Downloadable and
Shareable Materials
These resources provide even more information about the NavDx test. Please download and review, or print and use.
Blood Draws at Your Convenience
Mobile phlebotomy services lets you choose the best place for your blood draws.
Additional Resources
Helpful information for patients and their loved ones, from the Centers for Disease Control and Prevention (CDC), National Comprehensive Cancer Network (NCCN), and American Cancer Society (ACS).
Convenient and Secure Payment Portal
Pay your insurance plan-associated costs for the NavDx test through our secure patient payment portal.